Oryx 1 gm/vial (IM Injection)

1 gm vial: ৳ 200.00

Medicine Details

Indications

  • Lower respiratory tract infections
  • Acute Bacterial Otitis Media
  • Skin and skin structure infections
  • Urinary tract infections
  • Gonorrhea
  • Bacterial Septicemia
  • Bone and joint infections
  • Meningitis
  • Prevention of postoperative infections
  • Perioperative prophylaxis of infections associated with surgery

Pharmacology

Ceftriaxone is a 3rd generation broad-spectrum parenteral cephalosporin antibiotic with potent bactericidal activity against a wide range of Gram-positive and Gram-negative organisms. It kills bacteria by interfering with the synthesis of the bacterial cell wall. Ceftriaxone has a long plasma elimination half-life of about 6 to 9 hours, which allows for once-daily dosage. It is not metabolized in the body and is highly protein bound (95%).

Dosage

  • Adult:
    • 1 to 2 gm by intravenous or intramuscular administration once a day
    • 1 to 2 g IV or IM once a day (or in equally divided doses twice a day) for various infections
    • Max dose: 4 gm/day
  • Infants and Children (01 month or older):
    • 50 to 75 mg/kg intravenously or intramuscularly once a day
    • Duration: 4 to 14 days; longer in complicated infections

Administration

  • Preparation of Solutions for Intramuscular / Intravenous Injections
  • For Intramuscular Injection: 250 mg or 500 mg Ceftriaxone should be dissolved in Lidocaine HCI 1% injection
  • For Intravenous Injection: 250 mg or 500 mg Ceftriaxone should be dissolved in Water for injection

Interaction

No drug interactions reported

Contraindications

Not to be given to patients with a history of hypersensitivity to cephalosporin antibiotics

Side Effects

  • Gastro-intestinal effects including diarrhea, nausea, and vomiting
  • Cutaneous reactions including rash, urticaria, and edema
  • Hematologic reactions including eosinophilia and thrombocytopenia
  • Hepatic reactions including elevations of SGOT or SGPT
  • CNS reactions including nervousness, confusion, and headache
  • Local phlebitis occurs rarely following intravenous administration

Pregnancy & Lactation

Safety in human pregnancy not established; caution in lactating mother

Precautions & Warnings

  • Anaphylactic shock may occur
  • Gallbladder sludge detected in rare cases
  • Regular blood picture checks during prolonged treatment

Use in Special Populations

Must not be given to premature and newborn neonates (up to 28 days of age)

Overdose Effects

No specific antidote; treatment should be symptomatic

Therapeutic Class

Third generation Cephalosporins

Storage Conditions

Store vial in a cool, dry place (below 30° C), away from light & moisture; Keep out of the reach of children

Related Brands